Navigation Links
JAG Media Holdings, Inc. Announces Agreement with The Investor Relations Group, Inc.
Date:9/11/2009

MISSISSAUGA, Ontario, Sept. 11 /PRNewswire-FirstCall/ -- JAG Media Holdings, Inc. (OTC Bulletin Board: JAGH) has entered into an agreement with The Investor Relations Group, Inc. ("IRG"), pursuant to which IRG will provide various investor relations and public relations services for the Company in accordance with the terms of the agreement. As of Tuesday, September 15th, all stockholders should address any inquiries directly to IRG.

"We are very excited to begin working with IRG in connection with the Company's investor relations and public relations programs," said Dr. Yahia Gawad, Chief Executive Officer of JAG Media. "Dian Griesel, PhD, IRG's founder and CEO, has vast experience in the life sciences area and we are confident that her experience and the resources of IRG will be very effective in helping stockholders, media outlets and the general public alike better understand CardioGenics and the potential of its point-of-care diagnostic platform, related tests and products," continued Gawad.

"Dr. Gawad is a proven success in developing cardiac diagnostic test products. Over the past eighteen years, he has displayed noteworthy talent for taking products through development, regulatory approvals and commercialization. All of us at The Investor Relations Group are honored to have been chosen to help raise the awareness of the portfolio currently being developed by Dr. Gawad and his team," said Dian Griesel, founder and CEO of IRG.

A Current Report on Form 8-K containing further details regarding the IRG agreement will be filed by the Company and will be available on EDGAR.

About JAG Media Holdings, Inc. and its CardioGenics Subsidiaries

Through its CardioGenics subsidiaries, the Company develops technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. It has developed the QL Care Analyzer, a proprietary Point Of Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. The Company's principal offices are located in Mississauga, Ontario, Canada.

Through its Pixaya subsidiaries, the Company also provides Internet-based equities research and financial information that offers its subscribers a variety of stock market research, news and analysis, including "JAG Notes", the Company's flagship early morning consolidated research product.


'/>"/>
SOURCE JAG Media Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Catholic Health Association: Census Bureau Report and President Obama Make Strong Case for Bold, Immediate Action on Health Reform
2. BioInformatics, LLC New Report - New Media Marketing Channels: Creating Effective Online Life Science Promotional Videos
3. AUDIO from Medialink and Pfizer: September is Pain Awareness Month
4. Anthem Blue Cross and Blue Shield in Wisconsin Harnesses Social Media to Interact with Members
5. Media registration for ECCO 15 -- ESMO 34 multidisciplinary cancer congress
6. Health Club Media Network Adds Crunch Health Club Chain
7. Census Bureau News Media Advisory: Census Bureau to Announce Findings for Income, Earnings, Poverty and Health Insurance Coverage
8. Advanced Health Media Named to 2009 Inc. 5000 List of Americas Fastest Growing Private Companies
9. AUDIO from Medialink, Boehringer Ingelheim Pharmaceuticals, Inc. & Pfizer Inc.: Coping with Chronic Obstructive Pulmonary Disease (COPD)
10. MPA Media Launches New Chiropractic Publication, Dynamic Chiropractic PracticeINSIGHTS
11. PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop ... Mirroring360 Pro . This new addition to the Mirroring360 product family combines device ... business. , Mirroring360 Pro enables educators, business professionals and individuals to stream or ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President ... are preparing for how his administration could impact the employee benefits industry. James ... changes are most likely to make it through Congress. His discussion will focus ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like to ... a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, ... offers this revolutionary treatment with or without a referral. , Wilckodontics is ...
(Date:4/25/2017)... ... 2017 , ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace ... help but be heartened by the industry’s current surge. But another thing that unifies ... smell.” At last they can simply, safely and effectively end their aroma anguish ...
(Date:4/25/2017)... Fl (PRWEB) , ... April 25, 2017 , ... There ... Memorial Regional Hospital, according to a special report in the May issue of Consumer ... its highest quality ranking for results achieved during and after coronary bypass and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Tenn. and DALLAS , April 19, 2017 ... announced that the first patients in Nashville ... device in the Lower Esophageal Sphincter Stimulation for GERD ... implantable device designed to provide long-term reflux control by ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/19/2017)... 2017  New research provides evidence that an old drug ... a study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... Parkinson,s disease, the oral drug levodopa has long been considered ... as the disease progresses, the effects of the medication can ...
Breaking Medicine Technology: